Kenneth Fredrick Schulz

Kenneth Fredrick Schulz's AcademicInfluence.com Rankings

Mathematics

#3729

World Rank

#5444

Historical Rank

Statistics

#179

World Rank

#228

Historical Rank

mathematics Degrees

Download Badge

Mathematics

Kenneth Fredrick Schulz's Degrees

PhD Medical Statistics University of Oxford
Masters Medical Statistics University of Oxford

Why Is Kenneth Fredrick Schulz Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Kenneth Fredrick Schulz's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials (2011) (21564)
CONSORT 2010 Statement: Updated Guidelines for Reporting Parallel Group Randomised Trials (2010) (6599)
Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. (1995) (6119)
CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials (2010) (4451)
CONSORT 2010 Explanation and Elaboration: updated guidelines for reporting parallel group randomised trials (2010) (4153)
CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials (2010) (4149)
The Revised CONSORT Statement for Reporting Randomized Trials: Explanation and Elaboration (2001) (3830)
CONSORT 2010 Explanation and Elaboration: updated guidelines for reporting parallel group randomised trials (2010) (3790)
SPIRIT 2013 statement: defining standard protocol items for clinical trials. (2013) (3679)
CONSORT 2010 Statement: Updated Guidelines for Reporting Parallel Group Randomized Trials (2010) (3478)
Improving the quality of reporting of randomized controlled trials. The CONSORT statement. (1996) (3429)
The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials (2001) (3409)
The CONSORT statement: revised recommendations for improving the quality of reports of parallel group randomized trials (2001) (3146)
SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials (2013) (3035)
The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials. (2001) (2451)
The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials (2003) (2329)
Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study (2008) (2157)
Extending the CONSORT statement to randomized trials of nonpharmacologic treatment: explanation and elaboration. (2008) (2118)
CONSORT 2010 Explanation and Elaboration: Updated guidelines for reporting parallel group randomised trials. (2010) (2066)
Interpretation of the evidence for the efficacy and safety of statin therapy (2016) (1290)
Bias and causal associations in observational research (2002) (1266)
CONSORT 2010 statement: Updated guidelines for reporting parallel group randomised trials (2010) (1253)
Increasing value and reducing waste in research design, conduct, and analysis (2014) (1144)
Better Reporting of Harms in Randomized Trials: An Extension of the CONSORT Statement (2004) (1135)
A catalogue of reporting guidelines for health research (2010) (924)
Influence of Reported Study Design Characteristics on Intervention Effect Estimates From Randomized, Controlled Trials (2012) (871)
Guidance for Developers of Health Research Reporting Guidelines (2010) (843)
Does the CONSORT checklist improve the quality of reports of randomised controlled trials? A systematic review (2006) (818)
Allocation concealment in randomised trials: defending against deciphering (2002) (817)
Blinding in randomised trials: hiding who got what (2002) (794)
The CONSORT Statement (1996) (744)
CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials (2010) (739)
Refining clinical diagnosis with likelihood ratios (2005) (717)
The CONSORT statement: revised recommendations for improving the quality of reports of parallel group randomized trials (2001) (694)
SPIRIT 2013 Statement: defining standard protocol items for clinical trials. (2015) (688)
Generation of allocation sequences in randomised trials: chance, not choice (2002) (680)
CONSORT Statement for Randomized Trials of Nonpharmacologic Treatments: A 2017 Update and a CONSORT Extension for Nonpharmacologic Trial Abstracts. (2017) (667)
CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. (2010) (663)
CONSORT 2010 statement: updated guidelines for reporting parallel group randomized trials. (2010) (647)
Consolidated standards of reporting trials (CONSORT) and the completeness of reporting of randomised controlled trials (RCTs) published in medical journals. (2012) (614)
An overview of clinical research: the lay of the land (2002) (606)
Uses and abuses of screening tests (2002) (514)
Descriptive studies: what they can and cannot do (2002) (506)
Sample size slippages in randomised trials: exclusions and the lost and wayward (2002) (504)
Assessing the quality of randomization from reports of controlled trials published in obstetrics and gynecology journals. (1994) (501)
Sample size calculations in randomised trials: mandatory and mystical (2005) (500)
CONSORT for Reporting Randomized Controlled Trials in Journal and Conference Abstracts: Explanation and Elaboration (2008) (485)
Methods and processes of the CONSORT Group: example of an extension for trials assessing nonpharmacologic treatments. (2008) (480)
Does use of the CONSORT Statement impact the completeness of reporting of randomised controlled trials published in medical journals? A Cochrane reviewa (2012) (479)
What contributions do languages other than English make on the results of meta-analyses? (2000) (470)
Subverting randomization in controlled trials. (1995) (458)
CONSORT 2010 Statement: Updated guidelines for reporting parallel group randomised trials. (2010) (419)
Case-control studies: research in reverse (2002) (419)
Erratum to: “CONSORT 2010 Explanation and Elaboration: updated guidelines for reporting parallel group randomised trials” [J Clin Epidemiol 2010;63(8):e1–37] (2012) (412)
Cohort studies: marching towards outcomes (2002) (407)
Compared to what? Finding controls for case-control studies (2005) (387)
Transparent and accurate reporting increases reliability, utility, and impact of your research: reporting guidelines and the EQUATOR Network (2010) (364)
WHO multicentre randomised trial of misoprostol in the management of the third stage of labour (2001) (343)
Multiplicity in randomised trials I: endpoints and treatments (2005) (342)
Statistical methods for assessing the influence of study characteristics on treatment effects in ‘meta‐epidemiological’ research (2002) (333)
Multiplicity in randomised trials II: subgroup and interim analyses (2005) (308)
A proposal for structured reporting of randomized controlled trials. The Standards of Reporting Trials Group. (1994) (299)
The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials. (2001) (258)
The Landscape and Lexicon of Blinding in Randomized Trials (2002) (241)
Endorsement of the CONSORT Statement by high impact factor medical journals: a survey of journal editors and journal 'Instructions to Authors' (2008) (237)
CONSORT for reporting randomised trials in journal and conference abstracts (2008) (226)
False alarms and pseudo-epidemics: the limitations of observational epidemiology. (2012) (224)
Unequal group sizes in randomised trials: guarding against guessing (2002) (218)
Prevention of uterine perforation during curettage abortion. (1984) (217)
Concealing treatment allocation in randomised trials (2001) (213)
MEASURES TO PREVENT CERVICAL INJURY DURING SUCTION CURETTAGE ABORTION (1983) (203)
Guidelines for Reporting Health Research: The EQUATOR Network's Survey of Guideline Authors (2008) (198)
Relation of completeness of reporting of health research to journals’ endorsement of reporting guidelines: systematic review (2014) (185)
Immediate postabortal insertion of intrauterine devices. (2004) (165)
Immediate post-partum insertion of intrauterine devices. (2003) (165)
Combination contraceptives: effects on weight. (2011) (163)
Blinding and exclusions after allocation in randomised controlled trials: survey of published parallel group trials in obstetrics and gynaecology (1996) (158)
The CONSORT Statement: revised recommendations for improving the quality of reports of parallel-group randomized trials 2001. (2005) (158)
Pregnancy loss, infant death, and suffering: legacy of syphilis and gonorrhoea in Africa. (1987) (158)
Randomised trials, human nature, and reporting guidelines (1996) (153)
The Good Clinical Practice guideline: a bronze standard for clinical research (2005) (146)
Making sense of odds and odds ratios. (2008) (143)
Helping editors, peer reviewers and authors improve the clarity, completeness and transparency of reporting health research (2008) (142)
Surrogate end points in clinical research: hazardous to your health. (2005) (138)
Describing reporting guidelines for health research: a systematic review. (2011) (132)
Mid-trimester abortion by dilatation and evacuation: a safe and practical alternative. (1977) (126)
Reporting of Multi-Arm Parallel-Group Randomized Trials: Extension of the CONSORT 2010 Statement (2019) (126)
Improving the reporting of randomised trials: the CONSORT Statement and beyond (2012) (111)
Assessing allocation concealment and blinding in randomised controlled trials: why bother? (2000) (110)
CONSORT 2010 changes and testing blindness in RCTs (2010) (107)
Non-steroidal anti-inflammatory drugs for heavy bleeding or pain associated with intrauterine-device use. (2006) (102)
Guidelines for Reporting Trial Protocols and Completed Trials Modified Due to the COVID-19 Pandemic and Other Extenuating Circumstances: The CONSERVE 2021 Statement. (2021) (100)
Antibiotic prophylaxis for intrauterine contraceptive device insertion. (1999) (99)
Update on the endorsement of CONSORT by high impact factor journals: a survey of journal “Instructions to Authors” in 2014 (2016) (95)
Steroidal contraceptives: effect on bone fractures in women. (2009) (94)
Continuous versus cyclic use of combined oral contraceptives for contraception: systematic Cochrane review of randomized controlled trials. (2006) (94)
[CONSORT for reporting randomized controlled trials in journal and conference abstracts: explanation and elaboration]. (2008) (92)
20 µg versus >20 µg estrogen combined oral contraceptives for contraception. (2013) (84)
Steroidal contraceptives: effect on carbohydrate metabolism in women without diabetes mellitus. (2014) (82)
Nonspecific side effects of oral contraceptives: nocebo or noise? (2011) (81)
Cochrane systematic reviews of IUD trials: lessons learned. (2007) (80)
Combination Estrogen–Progestin Contraceptives and Body Weight: Systematic Review of Randomized Controlled Trials (2004) (80)
Opportunities and challenges for improving the quality of reporting clinical research: CONSORT and beyond (2004) (76)
Abortions That Fail (1985) (76)
Non-latex versus latex male condoms for contraception. (2006) (76)
Immediate post-partum insertion of intrauterine devices: a Cochrane review. (2002) (74)
Combination contraceptives: effects on weight. (2014) (73)
Unbiased research and the human spirit: the challenges of randomized controlled trials. (1995) (72)
Skin patch and vaginal ring versus combined oral contraceptives for contraception. (2008) (72)
Assessing allocation concealment and blinding in randomised controlled trials: why bother? (2000) (68)
Strategies for communicating contraceptive effectiveness. (2008) (68)
Correspondence2010 Statement: updated guidelines for reporting parallel group randomised trials (2010) (67)
Estimators of relative risk for case-control studies. (1983) (66)
Local versus general anesthesia: which is safer for performing suction curettage abortions? (1979) (64)
The EQUATOR Network and reporting guidelines: Helping to achieve high standards in reporting health research studies. (2009) (64)
The EQUATOR Network: Enhancing the quality and transparency of health research through the use of reporting guidelines (2008) (63)
Steroidal contraceptives: effect on bone fractures in women. (2014) (63)
CONSORT 2010 Statement: updated guidelines for reporting parallel group randomized trials (2010) (61)
Steroid hormones for contraception in women with sickle cell disease. (2007) (60)
The risk of serious complications from induced abortion: do personal characteristics make a difference? (1985) (60)
1. The effect of delay and method choice on the risk of abortion morbidity. (1977) (60)
Combination contraceptives: effects on weight (Review). (2006) (59)
Continuous or extended cycle vs. cyclic use of combined oral contraceptives for contraception. (2005) (59)
Immediate post-partum insertion of intrauterine devices. (2010) (58)
Abortion utilization: does travel distance matter? (1976) (58)
Prophylactic antibiotics for intrauterine device insertion: a metaanalysis of the randomized controlled trials. (1999) (58)
Hormonal contraception during lactation. systematic review of randomized controlled trials. (2003) (58)
Randomized controlled trials of home uterine activity monitoring: a review and critique. (1992) (57)
Fertility awareness-based methods for contraception. (2004) (56)
Oral contraceptives for functional ovarian cysts. (2009) (55)
Triphasic versus monophasic oral contraceptives for contraception. (2006) (54)
[CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials (Chinese version)]. (2010) (54)
The risks associated with teenage abortion. (1983) (52)
Twenty micrograms vs. >20 microg estrogen oral contraceptives for contraception: systematic review of randomized controlled trials. (2005) (51)
Dilatation and evacuation procedures and second-trimester abortions. The role of physician skill and hospital setting. (1982) (51)
CONSORT 2010 checklist of information to include when reporting a randomised trial * (2010) (51)
The quest for unbiased research: Randomized clinical trials and the CONSORT reporting guidelines (1997) (51)
[The CONSORT statenent: Revised Recommendations For Improving the Quality of Reports of Parallel-Group Randomized Trials]. (2005) (50)
VASOPRESSIN REDUCES BLOOD LOSS FROM SECOND-TRIMESTER DILATATION AND EVACUATION ABORTION (1985) (49)
20 mcg versus >20 mcg estrogen combined oral contraceptives for contraception. (2005) (49)
Fertility awareness-based methods for contraception: systematic review of randomized controlled trials. (2005) (46)
The methodologic quality of randomization as assessed from reports of trials in specialist and general medical journals. (1995) (46)
20 µg versus >20 µg estrogen combined oral contraceptives for contraception. (2011) (46)
Nonhormonal Drugs for Contraception in Men: A Systematic Review (2005) (46)
Combination contraceptives: effects on weight. (2014) (45)
Turning a blind eye:Testing the success of blinding and the CONSORT statement (2004) (45)
Insertion of an intrauterine contraceptive device after induced or spontaneous abortion: a review of the evidence (2001) (44)
Prophylactic antibiotics for curettage abortion. (1984) (44)
Morbidity and mortality from second-trimester abortions. (1985) (43)
Maternal Health and Child Survival: Opportunities to Protect Both Women and Children from the Adverse Consequences of Reproductive Tract Infections (1992) (39)
Skin patch and vaginal ring versus combined oral contraceptives for contraception. (2003) (37)
Surrogate end points in women's health research: science, protoscience, and pseudoscience. (2010) (37)
Skin patch and vaginal ring versus combined oral contraceptives for contraception. (2013) (37)
20 microg versus >20 microg estrogen combined oral contraceptives for contraception. (2008) (37)
[Multiplicity in randomized trials I: Endpoints and treatments]. (2006) (36)
Triphasic versus monophasic oral contraceptives for contraception. (2006) (35)
Microbicides, meta-analysis, and the N-9 question. Where's the research? (1998) (35)
Combination injectable contraceptives for contraception. (2008) (35)
Sponge versus diaphragm for contraception: a Cochrane review. (2003) (35)
Steroidal contraceptives: effect on carbohydrate metabolism in women without diabetes mellitus. (2012) (34)
Peer review of statistics in medical research. Reporting power calculations is important. (2002) (33)
The public health impact of legal abortion: 30 years later. (2003) (33)
The influence of CONSORT on the quality of reporting of randomised controlled trials: an updated review (2011) (33)
Oral contraceptives for functional ovarian cysts. (2011) (32)
Triphasic versus monophasic oral contraceptives for contraception (Review). (2006) (32)
Immediate start of hormonal contraceptives for contraception. (2008) (32)
Assessing allocation concealment and blinding in randomised controlled trials: why bother? (2000) (32)
Midtrimester abortion. Intra-amniotic instillation of hyperosmolar urea and prostaglandin F2 alpha v dilatation and evacuation. (1984) (32)
Steroid hormones for contraception in men. (2007) (30)
Combined hormonal versus nonhormonal versus progestin-only contraception in lactation. (2003) (30)
Abortion surveillance at CDC: creating public health light out of political heat. (2000) (30)
Reducing Publication Bias Through Trial Registration (2007) (30)
Antibiotic prophylaxis for intrauterine contraceptive device insertion. (2000) (28)
Biphasic versus monophasic oral contraceptives for contraception. (2001) (27)
Immunization as therapy for recurrent spontaneous abortion: A review and meta‐analysis (1993) (27)
Immediate start of hormonal contraceptives for contraception. (2012) (27)
Allocation concealment in clinical trials. (2002) (26)
Measles vaccine efficacy: influence of age at vaccination vs. duration of time since vaccination. (1978) (26)
Preventing febrile complications of suction curettage abortion. (1985) (26)
Does journal endorsement of reporting guidelines influence the completeness of reporting of health research? A systematic review protocol (2012) (25)
CONSORT 2010 comments (2010) (25)
Midtrimester abortion by intraamniotic prostaglandin F2alpha. Safer than saline? (1977) (24)
Oral contraceptives for functional ovarian cysts. (2014) (24)
Spermicide used alone for contraception. (2013) (24)
Midtrimester abortion by dilatation and evacuation. (1978) (23)
Methodology citations and the quality of randomized controlled trials in obstetrics and gynecology. (1996) (23)
Safety of Local Versus General Anesthesia for Second-Trimester Dilatation and Evacuation Abortion (1985) (22)
Improving the Clarity and Transparency of Reporting Health Research: a Shared Obligation and Responsibility (2008) (22)
Non-latex versus latex male condoms for contraception. (2006) (21)
Harms of outcome switching in reports of randomised trials: CONSORT perspective (2017) (21)
Development of a combined database for meta‐epidemiological research (2010) (21)
Biphasic versus triphasic oral contraceptives for contraception. (2002) (21)
Guidelines for Reporting Health Research: A User's Manual: Simera/Guidelines for Reporting Health Research: A User's Manual (2014) (20)
Urea-prostaglandin versus hypertonic saline for instillation abortion. (1983) (20)
Nonlatex vs. latex male condoms for contraception: a systematic review of randomized controlled trials. (2003) (19)
Reducing publication bias of prospective clinical trials through trial registration. (2007) (19)
Delayed abortion in an area of easy accessibility. (1980) (19)
Hysterectomy as Treatment for Complications of Legal Abortion (1984) (18)
Clinical Research in Obstetrics and Gynecology:: A Baedeker for Busy Clinicians (2002) (17)
Steroid hormones for contraception in men. (2012) (17)
Methods of Midtrimester Abortion: Which Is Safest? (1977) (17)
Immediate postabortal insertion of intrauterine devices. (2002) (17)
Cervical cap versus diaphragm for contraception. (2002) (17)
meta-epidemiological study interventions and outcomes: estimates in controlled trials with different Empirical evidence of bias in treatment effect (2009) (16)
SEXUALLY TRANSMITTED DISEASES IN SUB-SAHARAN AFRICA (1986) (16)
Strategies for communicating contraceptive effectiveness. (2013) (16)
Local Versus General Anesthesia: Which Is Safer for Performing Suction Curettage Abortions (1981) (16)
Coagulopathy and induced abortion methods: rates and relative risks. (1983) (16)
Identifying neonatal risk factors and predicting neonatal deaths in Georgia. (1982) (15)
Sponge versus diaphragm for contraception. (2002) (15)
Continuous or extended cycle versus cyclic use of combined oral contraceptives for contraception (review). (2005) (15)
45A Failure to conceal treatment allocation schedules in trials influenced estimates of treatment effects (1994) (14)
Steroid hormones for contraception in men: systematic review of randomized controlled trials. (2005) (14)
Determining sample size and power in clinical trials: the forgotten essential. (1996) (14)
Peer review of statistics in medical research [2] (multiple letters) (2002) (14)
Randomized controlled trials. (1998) (14)
The Public Health Impact of Legal Abortion: 30 Years Later (2003) (13)
Reducing classification errors in cohort studies: the approach and a practical application. (1983) (13)
The methodology for developing a prospective meta-analysis in the family planning community (2011) (13)
Protocols, probity, and publication (2009) (13)
Resources for authors of reports of randomized trials: harnessing the wisdom of authors, editors, and readers (2011) (13)
Biphasic versus triphasic oral contraceptives for contraception. (2003) (13)
Measuring true contraceptive efficacy. A randomized approach--condom vs. spermicide vs. no method. (1998) (12)
‘Allocation concealment’: the evolution and adoption of a methodological term (2018) (12)
Research guidelines. (1995) (12)
World Health Organization studies of prostaglandins versus saline as abortifacients. A reappraisal. (1978) (12)
How to Develop a Reporting Guideline (2014) (12)
Biphasic versus triphasic oral contraceptives for contraception (Review). (2006) (12)
The comparative safety of second-trimester abortion methods. (1985) (11)
Get in the spirit with SPIRIT 2013: protocol content guideline for clinical trials. (2013) (11)
Meta-analyses of interventional trials done in populations with different risks (1995) (10)
Immediate post-abortal insertion of intrauterine devices. (2000) (8)
Biphasic versus monophasic oral contraceptives for contraception: a Cochrane review. (2002) (8)
[Improving the quality of reports on randomized controlled trials. Recommendations of the CONSORT Study Group]. (1998) (8)
Antibiotic prophylaxis for intrauterine contraceptive device insertion. (2001) (8)
Blinding is better than masking (2007) (8)
Abortion methods: morbidity, costs and emotional impact. 2. Costs of treating abortion-related complications. (1977) (8)
Steroidal contraceptives: effect on carbohydrate metabolism in women without diabetes mellitus. (2009) (8)
Steroidal contraceptives: effect on bone fractures in women. (2011) (8)
Randomized Trials for Improving the Quality of Reports of Parallel-Group The CONSORT Statement: Revised Recommendations (2009) (7)
The reporting of methods for reducing and detecting bias: an example from the WHO Misoprostol Third Stage of Labour equivalence randomised controlled trial (2003) (7)
Steroidal contraceptives: effect on carbohydrate metabolism in women without diabetes mellitus. (2007) (7)
Interpreting the number needed to treat. (2002) (7)
CONSORT statement requires closer examination (2002) (7)
Biphasic versus monophasic oral contraceptives for contraception. (2001) (7)
Microbicides meta-analysis and the N-9 question. Wheres the research? [editorial] (1969) (6)
THE CASE-EXPOSURE STUDY A FURTHER EXPLICATION AND RESPONSE TO A CRITIQUE (1986) (6)
Skin patch and vaginal ring versus combined oral contraceptives for contraception. (2010) (6)
A "randomized" controlled trial without randomization. (1996) (6)
Combination injectable contraceptives for contraception (review). (2005) (6)
Ambiguities and Confusions Between Reporting and Conduct (2014) (6)
Consolidated standards of reporting trials (CONSORT) and the quality of reporting of randomized controlled trials (2010) (6)
Midtrimester Abortion by Intraamniotic Prostaglandin F2α: Safer than Saline? (1977) (6)
Dilatation and evacuation for induced abortion in developing countries: advantages and disadvantages. (1980) (5)
An update to SPIRIT and CONSORT reporting guidelines to enhance transparency in randomized trials (2022) (5)
Reporting the clinical importance of randomized controlled trials. (2002) (5)
[Failures in sample size calculation in randomized trial: mandatory and mystical]. (2006) (5)
The EQUATOR Network: facilitating transparent and accurate reporting of health research (2008) (5)
Family planning and abortion: have they affected fertility in Tennessee? (1982) (4)
A faculty development course in obstetrics and gynecology. (2000) (4)
Randomized controlled trials in "Contraception": the need for "CONSORT" guidelines. (2001) (4)
The CONSORT Statement. Revised recommendations on improving the quality of reports on parallel-design randomized studies (2005) (4)
Das CONSORT Statement (2005) (3)
Steroid hormones for contraception in men (Review) (2012) (3)
Misoprostol for cervical priming prior to IUD insertion in nulliparous women (2010) (3)
Spermicide used alone for contraception. (2013) (3)
Fertility awareness-based methods for contraception (Review) (2007) (3)
Randomized controlled trials in cancer: improving the quality of their reports will also facilitate better conduct. (1998) (3)
A22 Methodological quality in randomized trials and statistical heterogeneity in meta-analyses (1996) (3)
Clinical Research in Obstetrics and Gynecology: More Tips for Busy Clinicians (2005) (3)
[Epidemiological methods 8: blinded randomized trial: what one covers up is what one obtains]. (2007) (3)
[CONSORT statement. Revised findings on quality improvement based on reports from randomized studies in parallel design]. (2005) (2)
Oral contraceptives for functional ovarian cysts (Protocol). (2006) (2)
Misoprostol vs. placebo prior to IUD insertion in nulliparous women: a prospective meta-analysis (2013) (2)
Effect of liberalized abortion on maternal mortality rates. (1978) (2)
Methodological quality and bias in randomised controlled trials. (1994) (2)
The Limitations of Observational Epidemiology (2012) (2)
THE REVISED CONSORT STATEMENT FOR REPORTING RANDOMIZED TRIALS: EXPLANATION AND ELABORATION (2001) (PART II) (2010) (2)
Immediate postabortal insertion of intrauterine devices. (2010) (2)
Steroidal contraceptives: effect on carbohydrate metabolism in women without diabetes mellitus. (2019) (2)
Instruments assessing risk of bias of randomized trials frequently included items that are not addressing risk of bias issues. (2022) (2)
Bogus participation in clinical trials. (2001) (2)
Cervical Cap versus Diaphragm for Contraception (2003) (2)
Local Versus General Anesthesia (1981) (2)
Interpreting the number needed to treat. Author's reply (2002) (1)
Combination contraceptives: effects on weight. (2008) (1)
Reflections on medical journals. (2002) (1)
Screening in clinical trials. Authors' reply (2002) (1)
A RANDOMIZED CONTROLLED TRIAL WITHOUT RANDOMIZATION. AUTHORS' REPLY (1996) (1)
Second-Trimester Induced Abortion in the United States (1981) (1)
Reporting randomized trials. (2009) (1)
A Priority List Based on Family Health International's Meeting (1986) (1)
Oxytocin augmentation of second-trimester abortion: safe or hazardous? (1980) (1)
Development of a combined database for meta‐epidemiological research (2011) (1)
Steroid hormones for contraception in men. (2004) (1)
Oral contraceptives for functional ovarian cysts (Review) (2014) (1)
RESTRICTED RANDOMIZATION IN RANDOMIZED CONTROLLED TRIALS. AUTHORS' REPLY (1995) (0)
Biphasic versus triphasic oral contraceptives for contraception. (2002) (0)
The pursuit of unbiased research: randomized controlled trials (2000) (0)
Sample size and the ethics of non-inferiority trials (2005) (0)
Restricted Randomization in Randomized Controlled Trials-Reply (1995) (0)
An Introduction To Epidemiologic Methods (2019) (0)
P42 Blinding and exclusions after randomization in controlled trials (1995) (0)
Sponge versus diaphragm for contraception (Review) (2013) (0)
Strategies for increasing concurrent barrier use among women using oral contraceptives. (2002) (0)
Biphasic versus monophasic oral contraceptives for contraception. (2003) (0)
Contraception Special Interest Group (CSIG) (2014) (0)
Immediate post-partum insertion of intrauterine devices. (2001) (0)
CHAPTER 5 Ambiguities and Confusions Between Reporting and Conduct (2014) (0)
Immediate start of combined hormonal contraceptives for contraception (2006) (0)
Re: Testing for blinding is the only way to determine whether a trial is blind (2018) (0)
Reflections on medical journals. Author's reply (2002) (0)
Steroidal contraceptives: effect on bone fractures in women. (2006) (0)
Combination contraceptives: effects on weight. (2003) (0)
Dr. Schulz responds (1995) (0)
Original research article Steroid hormones for contraception in men: systematic review of randomized controlled trials (2005) (0)
Influence of methodological quality on study conclusions. (2001) (0)
NOTICE: This document contains correspondence generated during peer review and subsequent revisions but before transmittal to production for composition and copyediting: (2019) (0)
Screening in clinical trials [8] (multiple letters) (2002) (0)
Interpreting the number needed to treat [4] (multiple letters) (2002) (0)
Vaginal ring vs. combined oral contraceptives for contraception: a systematic review (2007) (0)
[Epidemiological methods 7: secrecy of randomization in randomized studies: how one defends against decisions]. (2007) (0)
Reporting of Randomised Trials Reporting of Randomised Trials (0)
Cervical cap versus diaphragm for contraception (Review) (2012) (0)
Methods for randomisation, concealment and blinding in the WHO Misoprostol Third Stage of Labour Trial. [Abstract 6] (2002) (0)
Biphasic versus monophasic oral contraceptives for contraception. (2006) (0)
Combination injectable contraceptives for contraception. (2005) (0)
Screening in clinical trials (2002) (0)
Epidemiology research (2002) (0)
The CONSORT statement: Explanation and elaboration. Authors' reply (2002) (0)
Combination injectable contraceptives for contraception. (2013) (0)
Second-Trimester Abortions-Reply (1983) (0)
Sponge versus diaphragm for contraception. (2002) (0)
The Risks Associated with Teenage Abortion (1984) (0)
[Series Epidemiology 5 Multiplicity in randomized studies II: Subgroup analyzes and intermediate evaluations]. (2007) (0)
A scoping review identifies multiple comments suggesting modifications to SPIRIT 2013 and CONSORT 2010. (2023) (0)
Reflections on medical journals [5] (multiple letters) (2002) (0)
Midtrimester abortion procedures. (1979) (0)
Characteristics of Available Reporting Guidelines (2014) (0)
The CONSORT statement: Explanation and elaboration - In response (2002) (0)
Panel 1 : Potential benefits accruing dependent on those individuals successfully blinded (0)
Oral contraceptives for functional ovarian cysts. (2006) (0)
Biphasic versus triphasic oral contraceptives for contraception. (2001) (0)
Sexually transmitted diseases in Sub-Saharan Africa [letter] (1986) (0)
Spermicide used alone for contraception. (2005) (0)
Tips for reading the medical literature (2015) (0)
Reporting Randomized Trials. Authors' reply (2009) (0)
Author’s response to reviews Title: Anthropometric, Biochemical and Clinical Assessment of Malnutrition among Egyptian Children with Chronic Liver Diseases: A Single Institutional Cross-sectional Study Authors: (2019) (0)
Allocation concealment terminology: origins and evidence (2018) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Kenneth Fredrick Schulz?

Kenneth Fredrick Schulz is affiliated with the following schools:

University of Oxford